NASDAQ: DRIO - DarioHealth Corp.

Rentabilidad a seis meses: -44.38%
Rendimiento de dividendos: 0.00%
Sector: Healthcare

Calendario de promoción DarioHealth Corp.

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa DarioHealth Corp.

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move, which helps to prevent and treat the most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solutions; DarioEngage platform; and Dario blood glucose monitoring system.

más detalles
It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and Dario smart diabetes management solutions, including live clinical coaching, content, automated journeys, hardware, and lifestyle coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

IPO date 2014-10-06
ISIN US23725P2092
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.dariohealth.com
Цена ао 0.6553
Cambio de precio por día: -5% (0.6558)
Cambio de precio por semana.: -9.46% (0.6881)
Cambio de precio por mes: -9.72% (0.6901)
Cambio de precio en 3 meses.: -10.36% (0.695)
Cambio de precio en seis meses: -44.38% (1.12)
Cambio de precio por año: -59.28% (1.53)
Cambio de precio en 3 años.: -90.5% (6.56)
Cambio de precio en 5 años.: -92.19% (7.98)
Cambio de precio desde principios de año.: -20.75% (0.7861)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 1.95 7
P/BV 0.7331 10
P/E 1.29 10
EV/EBITDA -0.9564 0
Total: 8.38

Eficiencia

Nombre Significado Calificación
ROA, % 38.07 9
ROE, % 62.97 10
Total: 4.83

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0 0
Total: 0

Deber

Nombre Significado Calificación
Debt/EBITDA -0.5229 10
Total: 9.8

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 255.79 10
Rentabilidad Ebitda, % 91.21 9
Rentabilidad EPS, % -112.55 0
Total: 5.8
Más detalles

Instituciones Volumen Compartir, %
Nantahala Capital Management, LLC 4673506 15.87
Appian Way Asset Management LP 1322444 4.49
Y.D. More Investments Ltd 1288518 4.38
Phoenix Holdings Ltd. 1180813 4.01
Clal Insurance Enterprises Holdings Ltd 875964 2.98
Vanguard Group Inc 363042 1.23
Geode Capital Management, LLC 270573 0.92
Clarity Capital Partners LLC 170426 0.58
Blackrock Inc. 112619 0.38
LPL Financial LLC 109901 0.37

ETFCompartir, %Rentabilidad del año, %Dividendos, %
iShares Micro-Cap ETF 0.00664 17.09 1.54048
0.0117.091.54



Supervisor Título profesional Pago año de nacimiento
Mr. Erez Raphael CEO & Director 722.19k 1973 (52 año)
Dov Oppenheim Co-Founder & Production Chief N/A
Josh Fischer Senior Vice President of Operations & Compliance N/A
Claudia Levi Content & Communications Manager N/A
Mr. Jean Christophe Muyl Head of Commercialization North America N/A
Mr. Tomer Ben-Kiki Chief Technology Officer N/A 1971 (54 año)
Limor Drezner Chief People Officer N/A
Mr. Zvi Ben David CPA CFO, Treasurer & Secretary 342.58k 1961 (64 año)
Kat Parrella Investor Relations Manager
Ms. Mona Dean Chief Compliance Officer

DIRECCIÓN: United States, New York. NY, 18 West 18th Street - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.dariohealth.com